- Home
- UHS
as 11-15-2024 4:00pm EST
Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two key segments: Acute Care Hospital Services and Behavioral Health Services. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.
| Founded: | 1978 | Country: | United States |
| Employees: | N/A | City: | KING OF PRUSSIA |
| Market Cap: | 14.9B | IPO Year: | N/A |
| Target Price: | $227.31 | AVG Volume (30 days): | 831.1K |
| Analyst Decision: | Buy | Number of Analysts: | 17 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 15.03 | EPS Growth: | 57.82 |
| 52 Week Low/High: | $133.70 - $243.25 | Next Earning Date: | 10-24-2024 |
| Revenue: | $15,417,759,000 | Revenue Growth: | 9.93% |
| Revenue Growth (this year): | 11.17% | Revenue Growth (next year): | 6.34% |
Latest Universal Health Services Inc. News
UHS Breaking Stock News: Dive into UHS Ticker-Specific Updates for Smart Investing
Simply Wall St.
2 days ago
Universal Health Services' (NYSE:UHS) Returns Have Hit A Wall
Argus Research
5 days ago
UHS: Lowering target price to $226.00
Zacks
5 days ago
Zacks Industry Outlook HCA Healthcare, Tenet Healthcare, Universal Health, Acadia Healthcare and Community Health Systems
Zacks
6 days ago
5 Hospital Stocks Set to Thrive Amid Robust Industry Trends
Argus Research
12 days ago
UHS: Raising target price to $233.00
Zacks
13 days ago
Analyzing Universal Health's Q3 Earnings: To Buy or Keep Your Cool?
MT Newswires
18 days ago
Goldman Sachs Adjusts Price Target on Universal Health Services to $228 From $229
PR Newswire
19 days ago
UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT THE 2024 WOLFE RESEARCH HEALTHCARE CONFERENCE
Compare UHS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "UHS Universal Health Services Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.